Surgical Site Infection Control Market Size, Share, Analysis, Growth, 2032

Surgical Site Infection Control Industry Prospective:

The global surgical site infection control market size was worth around USD 5.7 billion in 2023 and is predicted to grow to around USD 9.5 billion by 2032, with a compound annual growth rate (CAGR) of roughly 5.9% between 2024 and 2032.

Request Free Sample

Surgical Site Infection Control Market: Overview

Surgical Site Infection (SSI) Control is the technique used to prevent infections at the surgical site. For instance, in sterile surgical procedures, the use of prophylactic antibiotics, postoperative wound care, preoperative sterilization and antiseptic protocols, and other precautions are included in these practices. The SSI control keeps the surgical site clean and safe during the procedure.

Effective SSI management seeks to lower the rate of infections, encourage quicker healing, and enhance overall surgical outputs. The Surgical Site Infection (SSI) control market is driven by several variables, such as the increasing number of surgical procedures, increased focus on patient safety, the emergence of wearable technologies, and many others. However, the high cost associated with advanced infection control impacted the industry's growth.

Key Insights

• As per the analysis shared by our research analyst, the global surgical site infection control market is estimated to grow annually at a CAGR of around 5.9% over the forecast period (2024-2032).
• In terms of revenue, the global surgical site infection control market size was valued at around USD 5.7 billion in 2023 and is projected to reach USD 9.5 billion by 2032.
• The growing prevalence of chronic disease is expected to drive the surgical site infection control market over the forecast period.
• Based on the product, the antibiotic prophylaxis products segment is expected to hold the largest market share over the forecast period.
• Based on the infection type, the Deep Incisional SSI segment is expected to dominate the market expansion over the projected period.
• Based on the surgery type, the cataract surgery segment is expected to capture a significant market share during the projected period.
• Based on the end user, the hospital segment is expected to hold the largest revenue share over the analysis period.
• Based on region, North America is expected to dominate the market during the forecast period.

Surgical Site Infection Control Market: Growth Drivers

Increasing number of geriatric populations drives market growth

A growing percentage of elderly individuals 65 and over is a defining feature of the demographic change occurring in many parts of the world. For instance, as per the information published by the World Health Organization, 1 in 6 people worldwide will be 60 years of age or older by 2030.

At that point, there will be 1.4 billion people over the age of 60, up from 1 billion in 2020. The number of people in the world who are 60 years of age or older will quadruple to 2.1 billion by 2050. The prevalence of chronic diseases like diabetes, hypertension, and cardiovascular disease is increasing and the growing age-related alterations in the immune system are also increasing.

Thus, older persons are more prone to SSIs. There is a greater need for infection control measures to reduce the risk of surgical site infections (SSIs) as the frequency of surgeries performed on older persons rises in tandem with the geriatric population.

For instance, according to research unveiled by the National Library of Medicine in March 2023, older persons aged 76–80 years had greater SSI rates following complete knee replacement surgery than those aged 61–65. Therefore, the aforementioned facts drive the surgical site infection control market.

Surgical Site Infection Control Market: Restraints

A stringent regulatory framework hinders market growth

The main obstacle preventing the surgical site infection control industry from expanding is the strict regulatory environment. The Food and Drug Administration (FDA) in the US regulates the use of chemicals in disinfectants, antiseptics, and other personal hygiene products. For these goods to be approved for usage, FDA requirements must be followed. Inappropriate use of chemical substances could result in health hazards if these regulations are broken.

Furthermore, product labeling is subject to regulatory laws. All ingredients and their corresponding amounts must be listed by businesses on product labels and packaging. They also have to give directions on how to use and store disinfectants and antiseptics safely. The risk of hospital-acquired infections and superficial incisional SSI (Surgical Site Infections) is increased by organ transplants, chronic illnesses, and surgeries including cesarean deliveries. Preventing these illnesses requires the use of cutting-edge antimicrobials and disinfectants.

Surgical Site Infection Control Market: Opportunities

Innovations in antimicrobial technologies offer a lucrative opportunity for market growth

Antimicrobial technology advancements are transforming surgical infection prevention by offering more effective and focused ways to fight surgical site infections. Surgical equipment antimicrobial coatings, including those that contain iodine or silver, significantly lower the risk of infection by efficiently preventing microbiological development on surfaces. Cutting-edge wound dressings that are integrated with bioactive substances like honey or antimicrobial peptides provide long-lasting protection and hasten the healing process.

Furthermore, new antiseptic treatments that contain higher concentrations of chlorhexidine gluconate are more effective at disinfecting the skin before surgery. Together, these developments strengthen infection control strategies, improving patient outcomes and lowering problems related to healthcare. Hence, supporting the market for surgical site infection management.

Surgical Site Infection Control Market: Challenges

High cost associated with advanced technologies poses a major challenge to market expansion

For healthcare facilities with tight budgets, the high expenses of cutting-edge infection control equipment and technology can be a significant obstacle.

For instance, complex systems like automatic UV-C disinfection machines and sophisticated air filtering systems might be unaffordable, particularly when you factor in the extra expenses for staff training, maintenance, and installation. These costs may be difficult for smaller or less well-funded healthcare facilities to handle, which may restrict their capacity to implement necessary infection control strategies and, as a result, compromise patient safety and treatment quality.

Surgical Site Infection Control Market: Report Scope

Surgical Site Infection Control Market: Segmentation

The global surgical site infection control industry is segmented based on product, infection type, surgery type, end user, and region.

Based on the product, the global surgical site infection control market is bifurcated into antibiotic prophylaxis products, wound care dressings, surgical drapes, surgical clippers, antiseptics and disinfectants, wound irrigation products, and others. The antibiotic prophylaxis products segment is expected to hold the largest market share over the forecast period. The growth is attributed to factors such as the high cost of antibiotics, their acceptance as an established preventive method for SSIs, and the availability of patient-friendly dosage forms like tablets and capsules.

Based on the infection type, the global surgical site infection control industry is bifurcated into Superficial Incisional SSI, Deep Incisional SSI, and Organ or Space SSI. The Deep Incisional SSI segment is expected to dominate the market expansion over the projected period. The need for efficient SSI control strategies has increased as a result of the global increase in surgical procedures. Furthermore, stricter regulations by health organizations and increased awareness of illnesses linked to healthcare are driving market expansion.

Based on the surgery type, the global surgical site infection control market is segmented into cesarean section, gastric bypass, cataract surgery, dental restoration, and others. The cataract surgery segment is expected to capture a significant market share during the projected period. With millions of treatments performed each year, cataract surgery is one of the most common surgeries performed globally. The significant number of these procedures emphasizes how crucial it is to implement efficient infection control strategies to avoid SSIs.

Based on the end user, the global surgical site infection control industry is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment is expected to hold the largest revenue share over the analysis period. The increased need for efficient SSI control measures is a result of the growing number of surgeries carried out in hospitals throughout the world. To reduce SSIs, hospitals must also adhere to strict healthcare legislation and norms, which encourage the use of cutting-edge infection control tools and procedures.

Surgical Site Infection Control Market: Regional Analysis

North America dominates the market over the projected period

North America is expected to dominate the global surgical site infection control market. The need for SSI control measures has increased as a result of an increase in hospital stays in the area brought on by operations and chronic illnesses. The National Cancer Institutes, for instance, estimates that 18.1 million people in the United States are predicted to have survived cancer as of January 2022. This amounts to roughly 5.4% of the total population.

Additionally, healthcare facilities are being forced to invest in efficient SSI control devices and methods due to strict rules and recommendations targeted at lowering hospital-acquired infections. In addition, the use of cutting-edge infection control tools and technologies in medical facilities is improving the efficacy of SSI preventive measures.

Surgical Site Infection Control Market: Competitive Analysis

The global surgical site infection control market is dominated by players like:

• 3M Company
• Ansell Limited
• Becton Dickinson and Company
• bioMerieux SA. (Institut Mérieux)
• Covalon Technologies Ltd.
• GAMA Healthcare Ltd.
• Getinge AB (Carl Bennet AB)
• Johnson & Johnson
• Kimberly-Clark Corporation
• Mölnlycke Health Care AB
• Prescient Surgical
• Steris Corporation

The global surgical site infection control market is segmented as follows:

By Product

• Antibiotic Prophylaxis Products
• Wound Care Dressings
• Surgical Drapes
• Surgical Clippers
• Antiseptics and Disinfectants
• Wound Irrigation Products
• Others

By Infection Type

• Superficial Incisional SSI
• Deep Incisional SSI
• Organ or Space SSI

By Surgery Type

• Cesarean Section
• Gastric Bypass
• Cataract Surgery
• Dental Restoration
• Others

By End User

• Hospitals
• Ambulatory Surgical Centers
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa